Trial
NCT04203056
Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of California, Los Angeles
Collaborators
Alkermes, Inc.
Condition
Schizophrenia
Intervention
Aripiprazole Lauroxil
Why stopped
Withdraw of financial support by industry collaborator
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-11-28